- Home
- FLNT vs TPST Comparison
FLNT vs TPST Comparison
Compare FLNT & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- TPST
- Stock Information
- Founded
- FLNT 2010
- TPST 2011
- Country
- FLNT United States
- TPST United States
- Employees
- FLNT N/A
- TPST N/A
- Industry
- FLNT Advertising
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- FLNT Consumer Discretionary
- TPST Health Care
- Exchange
- FLNT Nasdaq
- TPST Nasdaq
- Market Cap
- FLNT 47.1M
- TPST 27.2M
- IPO Year
- FLNT N/A
- TPST N/A
- Fundamental
- Price
- FLNT $2.86
- TPST $0.92
- Analyst Decision
- FLNT Hold
- TPST Strong Buy
- Analyst Count
- FLNT 1
- TPST 4
- Target Price
- FLNT $4.00
- TPST $20.00
- AVG Volume (30 Days)
- FLNT 26.1K
- TPST 2.0M
- Earning Date
- FLNT 02-27-2025
- TPST 11-12-2024
- Dividend Yield
- FLNT N/A
- TPST N/A
- EPS Growth
- FLNT N/A
- TPST N/A
- EPS
- FLNT N/A
- TPST N/A
- Revenue
- FLNT $261,976,999.00
- TPST N/A
- Revenue This Year
- FLNT N/A
- TPST N/A
- Revenue Next Year
- FLNT $6.23
- TPST N/A
- P/E Ratio
- FLNT N/A
- TPST N/A
- Revenue Growth
- FLNT N/A
- TPST N/A
- 52 Week Low
- FLNT $2.31
- TPST $0.70
- 52 Week High
- FLNT $4.50
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- FLNT 56.04
- TPST 53.12
- Support Level
- FLNT $2.53
- TPST $0.85
- Resistance Level
- FLNT $2.91
- TPST $1.05
- Average True Range (ATR)
- FLNT 0.13
- TPST 0.09
- MACD
- FLNT 0.02
- TPST 0.02
- Stochastic Oscillator
- FLNT 87.50
- TPST 60.27
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers they are seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.